University of Virginia
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1819-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.virginia.edu
Echocardiography as Risk-Assessment for Major Adverse Cardiac Events in Major Vascular Surgery Patients
Completed
- Conditions
- Right-Sided Heart FailureLeft-Sided Heart FailureHeart Valve Diseases
- First Posted Date
- 2021-04-08
- Last Posted Date
- 2024-06-14
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 813
- Registration Number
- NCT04836702
ZILRETTA™ for Treatment of Idiopathic Adhesive Capsulitis
Phase 1
Terminated
- Conditions
- Adhesive CapsulitisFrozen ShoulderAdhesive Capsulitis of Shoulder
- Interventions
- First Posted Date
- 2021-04-05
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 39
- Registration Number
- NCT04831255
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Alpha-gal Pork Challenge
Not Applicable
- Conditions
- Allergy;Food
- First Posted Date
- 2021-04-02
- Last Posted Date
- 2021-04-02
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 54
- Registration Number
- NCT04828317
Adaptive Biobehavioral Control (ABC) of Automated Insulin Delivery
Not Applicable
Completed
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Device: Web Simulation Tool (WST)Device: Auto Titration Module (ATM)Device: Behavioral Adaptation Module (BAM)Device: Automated Insulin Delivery (AID) System
- First Posted Date
- 2021-03-05
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 31
- Registration Number
- NCT04784637
- Locations
- 🇺🇸
University of Virginia Center for Diabetes Technology, Charlottesville, Virginia, United States
Effectiveness of Exparel TAP Block in Breast Free Flap Reconstruction
Phase 4
Completed
- Conditions
- Postoperative PainBreast Reconstruction
- Interventions
- Drug: Liposomal bupivacaine TAP block
- First Posted Date
- 2021-03-02
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 117
- Registration Number
- NCT04777591
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
🇺🇸University of Virginia Medical Center, Charlottesville, Virginia, United States
Impaired Glucose Tolerance and Cognition in MS
Terminated
- Conditions
- Multiple Sclerosis
- First Posted Date
- 2021-02-10
- Last Posted Date
- 2021-02-10
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 7
- Registration Number
- NCT04748302
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL
Phase 2
Recruiting
- Conditions
- PTCL
- Interventions
- First Posted Date
- 2021-02-10
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 50
- Registration Number
- NCT04747236
- Locations
- 🇺🇸
Duke University, Durham, North Carolina, United States
🇺🇸Icahn School of Medicine at Mount Sinai, New York, New York, United States
🇺🇸University of Virginia, Charlottesville, Virginia, United States
Efficacy of Contrast Enhanced Voiding Urosonography for Urodynamic Studies
- Conditions
- Neurologic DysfunctionNeurogenic BladderMyelomeningoceleTethered Cord SyndromeBladder, NeurogenicUrologic Diseases
- Interventions
- Drug: Contrast Enhanced Voiding Urosonography with Urodynamic TestingDiagnostic Test: Urodynamic Testing
- First Posted Date
- 2021-02-04
- Last Posted Date
- 2021-04-28
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 105
- Registration Number
- NCT04738539
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Reduction in Number of Botox Injections for Urgency Urinary Incontinence
Not Applicable
Recruiting
- Conditions
- Urgency Urinary Incontinence
- Interventions
- Procedure: Experimental Arm (5 Botox injections)Procedure: Standard of care (15 Botox injections)
- First Posted Date
- 2021-02-01
- Last Posted Date
- 2025-01-28
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 56
- Registration Number
- NCT04731961
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Effect of Postprandial Hyperglycemia on Vasculature in Type 1 Diabetes and Healthy Adults
Completed
- Conditions
- Hyperglycemia, PostprandialType 1 Diabetes
- Interventions
- Dietary Supplement: Mixed Meal
- First Posted Date
- 2021-01-29
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 36
- Registration Number
- NCT04730882
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
© Copyright 2025. All Rights Reserved by MedPath